Pathstone Family Office’s Elanco Animal Health ELAN Stock Holding History

Pathstone Family Office’s Portfolio ELAN Stock Details ELAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$333K	Buy	+29,668	New	+$345K	﹤0.01%	1249

Other funds holding ELAN

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

SCM

Shapiro Capital Management Atlanta, Georgia $1.6B AUM 13.27% 1-Year Est. Return

BCIM

Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Pathstone Family Office's ELAN Position: Q3 2023 in Review

Pathstone Family Office opened a new position in Elanco Animal Health (ELAN) in Q3 2023: 29,668 shares worth $333K. The stake represents ﹤0.01% of the portfolio and ranks #1249 among its holdings.

350 funds tracked by Wall St. Rank hold ELAN as of Q3 2023.

Pathstone Family Office held 29,668 shares of Elanco Animal Health worth $333K as of Q3 2023.
Elanco Animal Health was a new Pathstone Family Office position in Q3 2023.
Elanco Animal Health made up ﹤0.01% of Pathstone Family Office's portfolio in Q3 2023, its #1249 holding.
350 funds tracked by Wall St. Rank held Elanco Animal Health as of Q3 2023.

Based on Pathstone Family Office's 13F filing for Q3 2023, filed 8 Nov 2023.